drugset / Trial / NCT03492047
N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients
Phase 1/2
Completed
75 enrolled
Ain Shams University
Nasser Institute For Research and Treatment · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the effect of N-acetyl cysteine in combination with paclitaxel on the clinical outcomes of patients with peripheral neuropathy, paclitaxel-induced peripheral neuropathy affect quality of life in cancer patients. new therapeutic approches such as the antioxidant N-acetyl cysteine, showed to has neuroprotective effect, the aim of the study is to evaluate the effect of N- acetylcysteine(NAC) administration in the prevention of paclitaxel-Induced peripheral neuropathy.
Timeline
- Start
- 2018-04-01
- Primary completion
- 2019-04-01
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |